Across the three pivotal trials, peak mean body-weight reductions rank retatrutide 12 mg at 24.2% (48 weeks, Phase 2), tirzepatide 15 mg at 22.5% (72 weeks, Phase 3), and semaglutide 2.4 mg at 14.9% (68 weeks, Phase 3) [1][2][5]
The standard regimen involves weekly self-administered injections, with dose adjustments made by your medical provider as needed throughout the program
Eliquis (apixaban), Bristol Myers Squibb and Pfizers blood thinner, has base patent protection expiring in 2026-2028 depending on jurisdiction, with secondary patents that will be contested [51]
The Bottom Line Tirzepatide is one of the most powerful and clinically validated weight-loss treatments available
PlexusDx offers GLP-Squared Injection (semaglutide plus tirzepatide, at $289/mo month-to-month, or from $249/mo on the 6-month plan) for patients whose response plateaus on tirzepatide alone
Comparing to dermal fillers: fat transfer lasts years rather than the 618 months of most hyaluronic acid fillers